Sheabul Hoque

Sheabul Hoque has a diverse work experience spanning over the years. Sheabul started their career at Rilys Redditch in 2009 as an Assistant Manager, eventually being promoted to head waiter and then taking on a managerial role. During their time at Rilys, Sheabul developed various transferable skills such as teamwork, organization, time management, communication, and problem-solving.

In 2017, Sheabul joined the University of Birmingham for doctoral research. Sheabul was awarded an MRC IMPACT DTP studentship for their research on stem cells in relation to Atrial Fibrillation and Autophagy. Additionally, Sheabul gained expertise in stem cell culture at the University of Nottingham and subsequently established an iPSC culture facility at the University of Birmingham.

Sheabul then transitioned to Lonza in 2020, working as a Bioassay Technologist. In this role, they ensured compliance with cGMP and ALCOA++ standards, producing documents to meet internal and external audit standards. Sheabul was also involved in GMP testing of Batch Release, Stability, and Characterization samples.

From 2022 to 2023, Sheabul worked at The Binding Site as a Supervisor, specializing in Protein Purification. Their responsibilities included managing multiple studies simultaneously to ensure the timely and successful supply of purified antigens/proteins. Sheabul also conducted technical reviews of GMP worksheets, ensuring their accuracy and completeness.

Currently, Sheabul Hoque is employed at Vaccitech as an Analytical Development Scientist, starting in 2023. Further details about their role, including specific responsibilities and the end date, were not provided.

Sheabul Hoque completed their Bachelor's Degree in Biochemistry from the University of Wolverhampton, where they studied from 2011 to 2015. Sheabul then pursued a Master's Degree in Molecular Biotechnology from the University of Birmingham, from 2015 to 2016.